TAVI in bicuspid aortic valves: no matter how hard you try, it won’t turn round
Comparative study on the behavior of TAVI prostheses implanted in bicuspid and tricuspid aortic valves, focusing on deformation, development of paravalvular leakage, and thrombosis.
Between a rock and a hard place: bovine or porcine aortic bioprosthetic valves? Which is better?
A retrospective observational study comparing the clinical outcomes of aortic valve replacement using porcine and bovine pericardial bioprostheses, based on nationwide administrative databases in Korea between 2003 and 2018.
Low-dose anticoagulation in patients with On-X® aortic prosthesis: Increased safety without compromising efficacy
First results from a prospective, multicenter, single-arm registry clinical study aimed at evaluating the safety of low-dose warfarin anticoagulation combined with aspirin in patients undergoing isolated aortic valve replacement with the On-X® prosthesis (Artivion®) after 5 years of follow-up, comparing these results with the historical control group from the randomized PROACT clinical trial.
Poor TAVI outcomes in patients younger than 65: make AVR great again!
A propensity score-matched analysis of state health department registries from California, New York, and New Jersey comparing 6-year morbidity and mortality outcomes following TAVI or surgical aortic valve replacement in patients younger than 65 years.
Beyond the operating room: how can cardiovascular surgeons and interventionalists safeguard their own health?
An analysis of a guide based on personal experiences, proposing exercise and nutrition strategies specifically designed to enhance the health and performance of cardiovascular surgeons and interventionalists during demanding workdays.
Anticoagulation and TAVI: comparison of two strategies
A randomized noninferiority study comparing two perioperative anticoagulation strategies for TAVI.
Aortic Root Remodeling: Is It Worth It?
Meta-analysis of publications on aortic root surgery preserving the tricuspid aortic valve aimed at identifying factors associated with residual aortic regurgitation and those linked to favorable valve competence outcomes.
COMMENCE at 7 years: Resilia tissue continues to perform well, though it is not infallible
This report details the 7-year outcomes of the COMMENCE study, which evaluates the results of aortic valve replacement using the Edwards Inspiris RESILIA® prosthesis.
